Consent for biobank tissue in somatic-cell nuclear transfer by Jones, David Albert & MacKellar, Calum
 1 
 
Consent for biobank tissue in somatic-cell nuclear transfer? 
 
The Human Fertilisation and Embryology Act 2008, which comes into force this October, 
has given a headache to biobanks in the UK. For the Act allows, on certain conditions, 
human tissue to be used for somatic cell nuclear transfers (hSCNT) with both human and 
non-human ova even though the tissue donor has not specifically consented to this 
procedure.1 Thus each biobank in the UK now has to decide how to respond to questions 
from donors and the general public about whether they can use their stored tissue in this 
way. 
 
Biobanks face a difficult problem in areas of research that are controversial. On the one 
hand, biobanks do not want to have to seek further consent for every particular use of 
tissue, which would be impractical. Instead they are keen to emphasise the validity of 
broad consent.2 On the other hand, if a biobank does not inform a donor of the possibility 
of a controversial use, the consent cannot be considered as informed consent.3 
Furthermore, on a pragmatic level, if donors subsequently hear that tissue was used in a 
manner which would offend them, without having sought their explicit consent, this use 
could undermine the important trust the public has for biobanks. 
 
This kind of loss of trust was witnessed in the 1990s after the scandals in Bristol Royal 
Infirmary and Alder Hey Children’s Hospital in Liverpool. In these hospitals, body parts of 
children were retained after postmortem examination on the assumption that this would be 
acceptable to parents. The subsequent public outcry led to an inquiry, governmental 
intervention, and restrictive regulation.4 
 
In relation to hSCNT, the question for biobanks is: if a scientist requests the use of biobank 
tissue for hSCNT, must the biobank contact donors for consent before the tissue is 
released? One possible response is exemplified by UK Biobank, the largest bank of 
human tissue in the UK.5,6 The Ethics and Governance Council of UK Biobank discussed 
the issue at a meeting in June, 2009. Their decision was to keep open the possible future 
use of biobank tissue for hSCNT without requiring further specific consent: “While there 
were varying opinions on the Council as to whether or not participants might expect the 
creation of human and human admixed embryos to fall outside UK Biobank’s general 
consent, this research use was not considered by the Council to be clearly ruled out in the 
broad consent model.”7 
 
UK Biobank is to be commended in setting up a transparent Ethics and Governance 
Council.8 Nevertheless, it is difficult to accept its claim that hSCNT could be covered by a 
broad consent to use of human tissue in research. There is good evidence that public 
opinion on hSCNT, and in particular hSCNT into non-human ova, is significantly divided.9 
Moreover, neither US federal funding nor European Union funding can be used for 
hSCNT.10,11 Thus hSCNT is subject to funding or regulatory differences which mark it out 
from other less controversial uses of human tissue. Accordingly, if the controversial 
character of hSCNT is not recognised by biobanks and tissue is used for hSCNT without 
explicit consent from the donor, there is a risk of another outcry similar to Alder Hey. 
 
A contrasting approach has been taken by Generation Scotland, one of the largest 
biobanks north of the border. In May, 2009, this biobank made a public commitment to 
seek explicit consent before this kind of use. “The Access Policy includes legally binding 
agreement that Generation Scotland undertakes never to use, or allow use of, any cells or 
tissue in its possession to create human embryos or human admixed embryos without 
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obtaining the prior explicit consent from donors to do this.”12 The decision of Generation 
Scotland does not rule out the use of its stored tissues for hSCNT, but does reassure 
present and future donors that their tissue will not be used for this purpose without their 
express consent. In this way the biobank ensures that the public continues to support the 
important research it facilitates. 
 
The approach exemplified by Generation Scotland is not only a safer option for biobanks. 
Their approach also represents best ethical practice. Indeed, the importance of informed 
consent has recently been reiterated in US President Barak Obama’s new National 
Institute of Health Guidelines for Human Stem Cell Research.10 The principle of explicit 
and informed consent is the very foundation for any research involving human participants 
and requiring public support. 
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